These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 20274525)

  • 41. CLINICAL PHARMACOLOGY OF 2-SULFANILAMIDO-3-METHOXYPYRAZINE.
    HERTING RL; LOPEZ F; SCHERFLING E; SYLVESTER JC; WIEGAND R
    Antimicrob Agents Chemother (Bethesda); 1964; 10():554-61. PubMed ID: 14287992
    [No Abstract]   [Full Text] [Related]  

  • 42. The effect of diisopropyl-fluorophosphate upon the response of the turtle heart to vagus stimulation.
    COHEN SL
    Fed Proc; 1947 Mar; 6(1 Pt 2):89. PubMed ID: 20342529
    [No Abstract]   [Full Text] [Related]  

  • 43. Pharmacology of 4-azophenyl-sulfanilamido-o-butylphenol.
    SAZONOVA NA
    Farmakol Toksikol; 1945; 8(2):49. PubMed ID: 21000679
    [No Abstract]   [Full Text] [Related]  

  • 44. [Clinical studies with 2-sulfanilamido-5-methoxypyrimidine].
    BUENGER P; KOCH G
    Arzneimittelforschung; 1961 Aug; 11():726-36. PubMed ID: 13874434
    [No Abstract]   [Full Text] [Related]  

  • 45. [PHARMACOKINETICS AND CLINICO-THERAPEUTIC EFFECTIVENESS OF 4-SULFANILAMIDO-5,6-DIMETHOXYPYRIMIDINE].
    HITZENBERGER G
    Wien Klin Wochenschr; 1964 May; 76():330-4. PubMed ID: 14222129
    [No Abstract]   [Full Text] [Related]  

  • 46. [Our experience with the use of 3-sulfanilamido-2-phenylpyrazole in gynecological practice].
    MILNER A; RODRIGUEZ AE
    Sem Med; 1960 Aug; 117():604-6. PubMed ID: 13770963
    [No Abstract]   [Full Text] [Related]  

  • 47. [Results obtained in 20 ambulatory patients treated with 2, 4-dimethoxy-6-sulfanilamido-1,3-diazine].
    CABLINSKI E; CAMPANA JM
    Sem Med; 1960 Jun; 116():1175-7. PubMed ID: 13689657
    [No Abstract]   [Full Text] [Related]  

  • 48. [Considerations on the use in otorhinolaryngology of a new low-dosage sulfonamide: 2-sulfanilamido-5-methylpyrimidine (Archisulfa)].
    SCORNAIENGHI G
    Gazz Med Ital; 1961 Sep; 120():344-6. PubMed ID: 13909895
    [No Abstract]   [Full Text] [Related]  

  • 49. [On ambulatory treatment of infections of the urinary tract with 2-sulfanilamido-5-methylpyrimidine].
    HASCHE-KLUENDER R
    Arztl Forsch; 1962 Feb; 16():I/94-9. PubMed ID: 13905122
    [No Abstract]   [Full Text] [Related]  

  • 50. [Antibacterial effectiveness of 2-sulfanilamido-5-methoxy-pyrimidine].
    KNOTT T; KUTZSCHE A; WALTER AM
    Arzneimittelforschung; 1961 Aug; 11():684-94. PubMed ID: 14457340
    [No Abstract]   [Full Text] [Related]  

  • 51. 2-Sulfanilamido-3-methoxypyrazine: a new long-action sulfonamide.
    CESANA A; VENTURA R
    Panminerva Med; 1962 Apr; 4():184-7. PubMed ID: 13877775
    [No Abstract]   [Full Text] [Related]  

  • 52. [On sulfonamide therapy of tonsillitis. Examination of the concentration of the long-action sulfonamide, 2-sulfanilamido-5-methylpyrimidine (Pallidin), in tonsillar tissue].
    NESSEL E
    Med Welt; 1961 Nov; 45():2358-61. PubMed ID: 14479077
    [No Abstract]   [Full Text] [Related]  

  • 53. [Clinical trial of a new broad-spectrum and long-acting antibacterial compound (2,4-dimethoxy-6-sulfanilamido-1,3-diazine)].
    GARCIA HERRERA E
    Medicina (Mex); 1959 Oct; 39():457-75. PubMed ID: 13826419
    [No Abstract]   [Full Text] [Related]  

  • 54. [Pyrazolic sulfanilamides. IX. Chloro-, methyl- and methoxy-derivatives of 1-phenyl-5-sulfanilamido-pyrazole].
    Alberti C; Tironi C
    Farmaco Sci; 1967 Jan; 22(1):58-75. PubMed ID: 6048934
    [No Abstract]   [Full Text] [Related]  

  • 55. The pharmacological properties of di-sulfanilyl-amido-phenolphthalein (DSP).
    van KAMPEN EJ; BRANDS GA; SIEMENS LM
    Acta Physiol Pharmacol Neerl; 1950; 1(4):603-16. PubMed ID: 14829305
    [No Abstract]   [Full Text] [Related]  

  • 56. [Synergistic effect of isoniazid and 6-(sulfanilamido)-2,4-dimethylpyrimidine on resistant tubercle bacteria; in vitro studies].
    GILLISSEN G
    Z Hyg Infektionskr; 1954; 139(6):498-504. PubMed ID: 13227127
    [No Abstract]   [Full Text] [Related]  

  • 57. [New pharmacological treatment of glaucoma verum; first trials with di-isopropyl fluorophosphate, dihydroergotamine and ethycol].
    GONZALEZ-POLA AM
    Archivos Soc Oftalmol Hisp Am; 1951 Jan; 11(1):50-63; disc 63-7. PubMed ID: 14820606
    [No Abstract]   [Full Text] [Related]  

  • 58. Clinical experience with a new sulfonamide, 5-methyl-3-sulfanilamido-isoxazole.
    CABEZON J; PRIGOT A; MEDINA A
    Curr Ther Res Clin Exp; 1962 Oct; 4():506-12. PubMed ID: 14017551
    [No Abstract]   [Full Text] [Related]  

  • 59. Synthesis of isoxazole-containing sulfonamides with potent carbonic anhydrase II and VII inhibitory properties.
    Altug C; Güneş H; Nocentini A; Monti SM; Buonanno M; Supuran CT
    Bioorg Med Chem; 2017 Feb; 25(4):1456-1464. PubMed ID: 28111158
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Physicochemical and pharmacological properties of some N1-substituted sulfanilamides].
    MOIRAGHI A; SANSALVADORE F; ANGELETTIE ; DIMODICA G
    Boll Chim Farm; 1961 Nov; 100():811-23. PubMed ID: 14475101
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.